2',3'-Dideoxycytidine (ddC)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 2',3'-Dideoxycytidine (ddC), covering 2021-10-27 to 2021-10-27. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT [Phase 2]